Structures by: Zabala-Lekuona A.
Total: 18
C16H14CoN4O6
C16H14CoN4O6
CrystEngComm (2020)
a=5.3010(2)Å b=10.0099(3)Å c=15.2097(6)Å
α=90° β=96.8820(10)° γ=90°
C16H10CdN4O4
C16H10CdN4O4
CrystEngComm (2020)
a=12.3609(15)Å b=9.9856(11)Å c=12.3887(14)Å
α=90° β=90° γ=90°
C16H14N4NiO6
C16H14N4NiO6
CrystEngComm (2020)
a=5.3050(3)Å b=9.9880(4)Å c=15.0820(7)Å
α=90° β=97.362(2)° γ=90°
C16H12CuN4O5
C16H12CuN4O5
CrystEngComm (2020)
a=10.1061(8)Å b=9.8617(7)Å c=14.7053(8)Å
α=90° β=94.716(2)° γ=90°
C24H33DyN4O12Zn
C24H33DyN4O12Zn
CrystEngComm (2017) 19, 2 256
a=11.3119(4)Å b=11.6798(6)Å c=25.6158(10)Å
α=82.889(4)° β=79.959(3)° γ=62.936(4)°
C24H33ErN4O12Zn
C24H33ErN4O12Zn
CrystEngComm (2017) 19, 2 256
a=11.2780(4)Å b=11.6650(5)Å c=25.6084(8)Å
α=82.789(3)° β=79.834(3)° γ=63.148(4)°
C24H33N4O12TmZn
C24H33N4O12TmZn
CrystEngComm (2017) 19, 2 256
a=11.1639(4)Å b=11.7254(5)Å c=25.6988(8)Å
α=83.027(3)° β=79.709(3)° γ=62.765(4)°
C24H33N4O12YZn
C24H33N4O12YZn
CrystEngComm (2017) 19, 2 256
a=11.2871(3)Å b=11.6719(4)Å c=25.6378(6)Å
α=82.855(2)° β=79.874(2)° γ=63.094(3)°
C27H25Br2ErN4O12Zn,4(CH4O),H2O
C27H25Br2ErN4O12Zn,4(CH4O),H2O
Dalton transactions (Cambridge, England : 2003) (2018) 48, 1 190-201
a=20.2750(4)Å b=13.9256(3)Å c=29.0584(12)Å
α=90° β=106.096(3)° γ=90°
[(9-anthracenecarboxylato-kO:kO')(N,N?-dimethyl-N,N?-bis(2-hydroxy-3-formyl-5-bromobenzyl)ethylenediamine)bis(nitrato-kO:kO')erbium(III)zinc(II)] (acetonitrile)
C35H29Br2ErN4O12Zn,(C2H3N)
Dalton transactions (Cambridge, England : 2003) (2018) 48, 1 190-201
a=12.5279(5)Å b=16.2474(5)Å c=20.5317(8)Å
α=105.959(3)° β=97.486(3)° γ=103.965(3)°
{[(N,N'-dimethyl-N,N'-bis(2-hydroxy-3-formyl-5-bromobenzyl)ethylenediamine) (diclofenac-kO:kO')bis(nitrato-kO:kO')dysprosium(III)zinc(II)] hydrate}
C34H30Br2Cl2DyN5O11Zn,(H2O)
Dalton transactions (Cambridge, England : 2003) (2018) 48, 1 190-201
a=15.3456(13)Å b=14.4928(10)Å c=20.6419(15)Å
α=90° β=113.963(5)° γ=90°
{[bis(N,N'-dimethyl-N,N'-bis(2-hydroxy-3-formyl-5-bromobenzyl)ethylenediamine)bis(2-hydroxysalicylato-kO:kO')(nitrato-kO:kO')(methanol-kO)didysprosium(III)dizinc(II)]nitrate penta(methanol)}
C57H60Br4Dy2N5O20Zn2,5(CH4O),(NO3)
Dalton transactions (Cambridge, England : 2003) (2018) 48, 1 190-201
a=11.960(5)Å b=13.985(5)Å c=24.559(5)Å
α=97.150(5)° β=95.160(5)° γ=110.313(5)°
{[(N,N'-dimethyl-N,N'-bis(2-hydroxy-3-formyl-5-bromobenzyl)ethylenediamine) (diclofenac-kO:kO')bis(nitrato-kO:kO')erbium(III)zinc(II)] hydrate}
C34H30Br2Cl2ErN5O12Zn,(H2O)
Dalton transactions (Cambridge, England : 2003) (2018) 48, 1 190-201
a=15.2858(6)Å b=14.4617(5)Å c=20.0422(7)Å
α=90° β=110.541(2)° γ=90°
C27H25Br2DyN4O12Zn,4(CH4O),H2O
C27H25Br2DyN4O12Zn,4(CH4O),H2O
Dalton transactions (Cambridge, England : 2003) (2018) 48, 1 190-201
a=20.3151(2)Å b=13.91860(10)Å c=29.0441(5)Å
α=90° β=106.0380(10)° γ=90°
{[bis(N,N'-dimethyl-N,N'-bis(2-hydroxy-3-formyl-5-bromobenzyl)ethylenediamine) bis(2-hydroxysalicylato-kO:kO')bis(nitrato-kO:kO') erbium(III)zinc(II)] di(acetonitrile)}
C27H26Br2ErN4O13Zn,2(C2H6N)
Dalton transactions (Cambridge, England : 2003) (2018) 48, 1 190-201
a=20.3420(6)Å b=14.7835(4)Å c=28.2615(12)Å
α=90° β=106.543(4)° γ=90°
[(9-anthracenecarboxylato-kO:kO')(N,N'-dimethyl-N,N'-bis(2-hydroxy-3-formyl-5-bromobenzyl)ethylenediamine)bis(nitrato-kO:kO')dysprosium(III)zinc(II)] (acetonitrile)
C35H29Br2DyN4O12Zn,(C2H3N)
Dalton transactions (Cambridge, England : 2003) (2018) 48, 1 190-201
a=12.5528(6)Å b=16.2599(8)Å c=20.5009(7)Å
α=105.887(4)° β=97.495(3)° γ=104.095(4)°
C27H25Br2ErN4O14Zn,2(C2H3N)
C27H25Br2ErN4O14Zn,2(C2H3N)
Dalton transactions (Cambridge, England : 2003) (2018) 48, 1 190-201
a=13.5160(10)Å b=20.7750(15)Å c=13.539(3)Å
α=90° β=91.534(3)° γ=90°
C58H64Br4Er2N4O18Zn2,4(CH4O),2(NO3)
C58H64Br4Er2N4O18Zn2,4(CH4O),2(NO3)
Dalton transactions (Cambridge, England : 2003) (2018) 48, 1 190-201
a=12.0449(5)Å b=22.2693(10)Å c=28.4885(14)Å
α=90° β=90.500(2)° γ=90°